Menu Search
Equities

Clarity Medical Group Holding Ltd

1406:HKG.HZ

Clarity Medical Group Holding Ltd

Actions
  • Price (HKD)0.56
  • Today's Change0.01 / 1.82%
  • Shares traded17.50k
  • 1 Year change-51.72%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024 07:41 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clarity Medical Group Holding Ltd is an investment holding company mainly engaged in the provision of ophthalmic consultation and treatment services. The Company mainly provides refractive treatment services including Smile surgeries, multifocal IOL (intraocular lens) replacements and ICL (implantable contact lens) implantations. In addition, the Company also provides treatments for other eye problems, such as standard cataract surgeries, laser procedures, PPV (pars-plana vitrectomy) surgeries, other treatments and surgeries, medical consultation and examination services and sales of prescriptions and others.

  • Revenue in HKD (TTM)207.77m
  • Net income in HKD-31.12m
  • Incorporated2019
  • Employees135.00
  • Location
    Clarity Medical Group Holding LtdRoom 1302, 13/F, 9 Queen's Road Central Hong KongHKG
  • Phone+852 34290031
  • Websitehttps://www.claritymedic.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.